This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $990,675
A precision medicine approach for treatment of low bone mass in Klinefelter Syndrome
CIHR · 2025 · Co-investigator
- $55,000
Development and Application of Cyclic Hydrazides as Organocatalysts
NSERC · 2024 · Principal investigator
- $25,000
Mechanistic studies of the reactivity of hydrazide organocatalysts
NSERC · 2023 · Principal investigator
A precision medicine approach for treatment of low bone mass in Klinefelter Syndrome
Principal investigators: St-Arnaud, René
Keywords: Bone; Cell Differentiation; Drug Development; Klinefelter Syndrome; Medicinal Chemistry; Metabolic Bone Disease; Osteoblasts; Preclinical Testing
Development and Application of Cyclic Hydrazides as Organocatalysts
Principal investigators: Gleason, James
Keywords: organocatalysis; hydrazides; iminium ions; asymmetric synthesis
Mechanistic studies of the reactivity of hydrazide organocatalysts
Principal investigators: Gleason, James JL
Keywords: density functional theory; hydrazides; kinetics; organic reaction mechanisms; organic synthesis
NMR Systems Upgrade for a Sustainable New Era
Principal investigators: Tsantrizos, Youla
Development of 14-3-3 protein/protein interaction agonists as potential therapies for spinal cord injury and stroke
Principal investigators: Gleason, James L; Fournier, Alyson Elise; Mittermaier, Anthony; Moitessier, Nicolas R
Keywords: 14-3-3 Protein; Fusiccocin A; Gcn1; Protein/Protein Interaction; Virtual Screening
Development and application of cyclic hydrazides as organocatalysts
Principal investigators: Gleason, James
Bifunctional non-secosteroidal vitamin D analogues as novel cancer therapeutics
Principal investigators: Gleason, James L; White, John H
Keywords: Cancer; Histone Deacetylases; Hybrid Molecules; Vitamin D; Xenograft Models
Development of General Approach to Substituted Bicylo[1.1.1]pentanes
Principal investigators: Gleason, James
Studies in Natural Product Synthesis and Catalysis of Pericyclic Reactions
Principal investigators: Gleason, James
Novel bivalent hybrid molecules with retinoic acid receptor agonistic and histone deacetylase inhibitory activity for cancer treatment
Principal investigators: Gleason, James L; Mader, Sylvie N
Keywords: Breast Cancer; Histone Deacetylase Inhibitors; Hybrid Molecules; Retinoic Acid Receptor Agonists
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.